Intake & Correspondence
Manual case intake remains one of the most resource-intensive and error-prone steps in the pharmacovigilance lifecycle. As safety data grows in volume and complexity, relying on manual processes creates significant risks and inefficiencies
Comon Intake Challenges:
- Manual extraction of safety information from emails, scanned PDFs, call transcripts, and handwritten documents requires significant time and human effort
- Manual data transcription often leads to incomplete or incorrect entries, impacting case quality and downstream processing
- Delays in capturing and triaging critical adverse event information can result in missed regulatory timelines and compliance breaches
- Highly trained PV professionals spend significant time on repetitive, low-value tasks like reading documents and entering dataManual processes increase the risk of human error, missed data points, or improper case triage—all of which can lead to findings during audits or inspections
Introducing Compier Intake – Inbox & Correspondence
It is a simplified multi-channel adverse event case intake, receipt and triaging solution with advanced semi-automation capabilities to facilitate fast and intelligent case processing. Compier Intake enables seamless AE intake, receipt, and triaging from various sources such as PDFs, emails, etc. through automated data point check and import of safety cases directly into the safety database. It also has a built-in Inbox for distribution of safety case related emails to different business partners and vendors. It also enables automated case filtering and ICSR intake from safety data obtained from the Canada Vigilance and Eudravigilance database.
Compier PV Ops Intake Automation and Agentic AI solutions are designed to transform this critical first step of the case lifecycle by leveraging intelligent automation, LLMs, and PV-trained agentic AI to reduce human workload, accelerate turnaround times, and enhance data quality.
Our agents extract relevant data points like adverse event terms, product details, reporter information, seriousness, and timelines streamlining the intake process before cases even enter Argus Safety or other drug safety systems from various structured and unstructured sources such as Emails & attachments (PDF, Word, scanned documents), Medical Information systems, Product complaint portals, Literature databases (e.g., Embase, PubMed), Call center transcripts and voice-to-text sources.
Key Benefits of Compier PV Ops Intake Automation & Agentic AI
Solution FAQs
We offer the Compier solution using the Software as a Service (SaaS) model with a standard Service Level Agreement (SLA). Additionally, Techsol shall also provide professional services to complete the successful implementation, configuration, validation, and global rollout of the Compier Intake & Mailbox modules along with the required system integrations.
Compier Intake & Mailbox modules are part of the PVOps Management platform. All modules are GxP compliant and meet FDA’s 21 CFR Part 11 and EU Annex 11 requirements. Techsol will provide the complete IQ/OQ validation documentation during the time of system implementation.
Our subject matter experts will deliver a hands-on Compier Intake application training to your application champions by using ‘Train-the-trainer’ approach. Trainings will be delivered primarily through web conference using standard presentations.
The Compier PV Aggregate solution architecture is designed to support various types of system integrations to eliminate manual effort and facilitate stakeholder collaboration across different PV business functions for increasing quality, compliance, and productivity.
The system supports a wide range of external system integrations using RESTFUL APIs and file-based data exchange transactions. Our approach towards integrations with third party solutions is based on industry standards, web services, APIs, and open architecture-based solutions.
Compier PV Ops Modules
End-to-End Pharmacovigilance Solutions
Latest Relevant Case Studies
December 29, 2022
Establishing an Integrated Global Drug Safety and Signal Management Cloud Solution
December 29, 2022
Argus Safety Cloud Implementation and Validation on Oracle Cloud for HUGEL Pharma
December 29, 2022
Serious Adverse Event (SAE) Management, Review and Reporting to DCGI during the COVID 19 Pandemic for an Ophthalmology Clinical Study
Latest Relevant Insights
August 30, 2021
Literature Screening – Process overview, challenges en-route and the scope for automation
